Condition
Recurrent Brain Tumor, Childhood
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (1)
P 2 (1)
Trial Status
Withdrawn1
Active Not Recruiting1
Terminated1
Clinical Trials (3)
Showing 3 of 3 trials
NCT03299309Phase 1Active Not Recruiting
PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma
NCT04897880Phase 2Terminated
A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT
NCT03955068Not ApplicableWithdrawnPrimary
Strict Classic Ketogenic Diet as a Therapy for Recurrent or Progressive and Refractory Brain Tumors in Children
Showing all 3 trials